DK0614886T3 - Forbindelser, der kan tilbageholdes i hjernen - Google Patents
Forbindelser, der kan tilbageholdes i hjernenInfo
- Publication number
- DK0614886T3 DK0614886T3 DK93916247.5T DK93916247T DK0614886T3 DK 0614886 T3 DK0614886 T3 DK 0614886T3 DK 93916247 T DK93916247 T DK 93916247T DK 0614886 T3 DK0614886 T3 DK 0614886T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- group
- substituted
- membered saturated
- brain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20399492 | 1992-07-30 | ||
JP20389792 | 1992-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0614886T3 true DK0614886T3 (da) | 1997-01-13 |
Family
ID=26514166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93916247.5T DK0614886T3 (da) | 1992-07-30 | 1993-07-30 | Forbindelser, der kan tilbageholdes i hjernen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5580904A (da) |
EP (1) | EP0614886B1 (da) |
JP (1) | JP2804177B2 (da) |
AT (1) | ATE144249T1 (da) |
CA (1) | CA2120248A1 (da) |
DE (1) | DE69305492T2 (da) |
DK (1) | DK0614886T3 (da) |
ES (1) | ES2096933T3 (da) |
GR (1) | GR3021394T3 (da) |
WO (1) | WO1994003424A1 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
ATE245420T1 (de) * | 1995-01-18 | 2003-08-15 | Alteon Inc | Verwendung von thiazoliumverbindungen zum verhindern und umkehren der bildung von endprodukten der fortgeschrittenen glykosylierung |
NO315930B1 (no) | 1995-01-18 | 2003-11-17 | Picower Inst For Medical Res T | Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser |
US5656261A (en) | 1995-01-18 | 1997-08-12 | The Picower Institute For Medical Research | Preventing and reversing advanced glycosylation endproducts |
US6121300A (en) | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
MXPA02008276A (es) * | 2000-02-23 | 2004-04-05 | Alteon Inc | Compuestos de tiazolio y tratamientos de trastornos asociados con el envejecimiento proteinico. |
US7045543B2 (en) | 2001-11-05 | 2006-05-16 | Enzrel Inc. | Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
US20050014747A1 (en) | 2003-04-18 | 2005-01-20 | Emily Reinhard | Dihydrothiazine prodrugs of thiazolium agents |
WO2006085149A2 (en) | 2004-12-22 | 2006-08-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
CN101007789B (zh) | 2006-01-27 | 2014-08-20 | 北京摩力克科技有限公司 | 取代五元氮杂环盐类化合物及其治疗蛋白老化相关疾病的用途 |
ES2296530B1 (es) * | 2006-09-01 | 2009-04-01 | Universidad De Barcelona | Compuestos lanzadera a traves de la barrera hematoencefalica y construcciones lanzadera-cargo. |
PL3851447T3 (pl) | 2006-10-12 | 2024-03-04 | Bellus Health Inc. | Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy |
ITMI20081167A1 (it) * | 2008-06-26 | 2009-12-27 | Ctg Pharma S R L | Composizioni farmaceutiche per il trattamento di malattie neurodegenerative |
EP2342356A4 (en) | 2008-09-29 | 2012-11-21 | Univ Ben Gurion | AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF |
CN102186804A (zh) * | 2008-10-20 | 2011-09-14 | 克塞诺波特公司 | 合成左旋多巴酯前药的方法 |
US8399513B2 (en) | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
CN110997693A (zh) | 2017-06-07 | 2020-04-10 | 阿德克斯公司 | τ聚集抑制剂 |
WO2019036725A2 (en) | 2017-08-18 | 2019-02-21 | Adrx, Inc. | PEPTIDE INHIBITORS OF TAU AGGREGATION |
CN109503561A (zh) * | 2018-12-22 | 2019-03-22 | 华中药业股份有限公司 | 一种呋喃硫胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751506B2 (ja) * | 1985-10-04 | 1995-06-05 | 孝男 岩崎 | 水虫等細菌性皮膚病の治療薬 |
JPH01319466A (ja) * | 1988-06-20 | 1989-12-25 | Nippon Chemiphar Co Ltd | バクロフェン誘導体、およびこれを含有する医薬品 |
JP2685514B2 (ja) * | 1988-07-07 | 1997-12-03 | 武田薬品工業株式会社 | ジスルフィド型サイアミン誘導体の無機酸塩の製造法 |
IT1245856B (it) * | 1991-04-03 | 1994-10-25 | Minnesota Mining & Mfg | Materiale fotografico a colori a piu' strati agli alogenuri d'argento comprendente un supersensibilizzatore disolfurico |
-
1993
- 1993-07-30 WO PCT/JP1993/001075 patent/WO1994003424A1/ja active IP Right Grant
- 1993-07-30 AT AT93916247T patent/ATE144249T1/de not_active IP Right Cessation
- 1993-07-30 CA CA002120248A patent/CA2120248A1/en not_active Abandoned
- 1993-07-30 JP JP6503872A patent/JP2804177B2/ja not_active Expired - Fee Related
- 1993-07-30 US US08/211,304 patent/US5580904A/en not_active Expired - Fee Related
- 1993-07-30 DE DE69305492T patent/DE69305492T2/de not_active Expired - Fee Related
- 1993-07-30 EP EP93916247A patent/EP0614886B1/en not_active Expired - Lifetime
- 1993-07-30 ES ES93916247T patent/ES2096933T3/es not_active Expired - Lifetime
- 1993-07-30 DK DK93916247.5T patent/DK0614886T3/da active
-
1996
- 1996-10-17 GR GR960402344T patent/GR3021394T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0614886A1 (en) | 1994-09-14 |
ES2096933T3 (es) | 1997-03-16 |
EP0614886A4 (en) | 1994-10-12 |
DE69305492T2 (de) | 1997-03-20 |
DE69305492D1 (de) | 1996-11-21 |
GR3021394T3 (en) | 1997-01-31 |
WO1994003424A1 (en) | 1994-02-17 |
EP0614886B1 (en) | 1996-10-16 |
CA2120248A1 (en) | 1994-02-17 |
JP2804177B2 (ja) | 1998-09-24 |
ATE144249T1 (de) | 1996-11-15 |
US5580904A (en) | 1996-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0614886T3 (da) | Forbindelser, der kan tilbageholdes i hjernen | |
EP1103552A4 (en) | BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE | |
DE69905131D1 (de) | Isochroman Verbindungen und Verfahren zu deren Produktion | |
KR930006027A (ko) | 엔케팔리나제 및 안지오텐신 전환 효소(ace)의 억제제로서 유용한 2-치환 인단-2-메르캅토아세틸아미드 유도체 | |
AU7137591A (en) | New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them | |
AU3515497A (en) | Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid | |
EP0324387A3 (en) | Composition for treatment of ischemic disorder in organs | |
WO1999020639A3 (en) | NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES | |
GR3000682T3 (en) | Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents | |
EP0293771A3 (en) | Cephalosporin compound and pharmaceutical composition thereof | |
WO1996028420A3 (en) | Preparation of n-arylmethyl aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives obtained therefrom and n-arylmethyl-ethanol-amine sulphonate esters as intermediates | |
TNSN88018A1 (fr) | Procedes de preparation de sels d'addition avec des acides, cristalises d'un compose de type cepheme. | |
KR960701029A (ko) | 하이드록시메틸 푸라잔 카복실산 유도체 및 심장 혈관 질환 치료에서의 이의 용도(Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions) | |
RU94032285A (ru) | Цефалоспориновые соединения, способ их получения, фармацевтическая композиция | |
ES8304971A1 (es) | Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos. | |
EP1057485A4 (en) | POTASSIUM CHANNEL ACTIVATORS | |
DE60136566D1 (de) | Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen | |
ES8101646A1 (es) | Un procedimiento para producir un compuesto opticamente ac- tivo | |
AU6595000A (en) | Dihydrobenzofuran derivatives, process for the preparation thereof and agents | |
ATE58129T1 (de) | Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung. | |
KR880000429A (ko) | T-부틸 에르골린 유도체 | |
EP0260605A3 (en) | Dihydropyridine-5-phosphonic acid cyclic ester | |
AR029004A1 (es) | Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana | |
ES2026548T3 (es) | Un procedimiento para preparar penemos. | |
DE3580173D1 (de) | Verbindungen mit antibakterieller wirksamkeit, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |